Every few years April 1st falls on a Friday, allowing us to put out our Potpourri on that day. As you might anticipate, one of our items this week is bogus, and it shouldn’t be too hard to figure out which one.
Read More
The FDA issues a draft guidance on the use of clinical pharmacogenomics, in particular the gathering of relevant pharmacogenomic data in early drug development studies.
The General Accounting Office looks into the controversial topic of Medicare Advantage plan reimbursement compared to Medicare FFS spending and finds that there is probably room to pressure rates downward.
A review article of high quality studies on the VHA’s telemedicine initiatives suggests that those interventions had positive health outcomes and may also lower overall health care utilization and cost.
The Institute of Medicine puts out two reports related to guidelines and the evidence supporting them which, if followed, should help ensure credible advances in scientific guidance for medical care.
Another edition of the Potpourri, featuring results on the Guided Care program, bundled payment experience, academic physician compensation, end-of-life care, hospital prices and costs, and geographic variation in Medicare spending.
A Deloitte report focuses on health spending which may not be captured in official accounts, finding over $360 billion of it, all borne by consumers, but it is not clear that the fact that consumers are responsible for this spending is a bad thing.
McKinsey publishes an article on disease management, focusing on overseas experience and finding that properly designed and managed programs can lower costs, improve outcomes and increase patient satisfaction.
GAO issued its latest trend report on drug prices, which confirmed that for branded medications prices continue to rise well above the rate of either Medical CPI or general inflation, but generics hold down overall cost rises.
The Medicare Payment Advisory Commission commented on the Medicare program’s proposed rule for a hospital value-based purchasing initiative, generally agreeing with CMS’ recommendations.
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts